COSCIENS Biopharma Inc. Weighted Average Exercise Price Of Share Options Exercised In Share-based Payment Arrangement2019
COSCIENS Biopharma Inc. (CSCIF) reported Weighted Average Exercise Price Of Share Options Exercised In Share-based Payment Arrangement2019 of $11.86 per share for the 12-month period ending 2023-12-31, per its 20-F filed 2025-04-09.
Financial Statements › Notes › Compensation Related Costs
ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019 · last filed 2026-03-25
USD/shares
| Period end | Weighted Average Exercise Price Of Share Options Exercised In Share-based Payment Arrangement2019 6 month | Weighted Average Exercise Price Of Share Options Exercised In Share-based Payment Arrangement2019 9 month | Weighted Average Exercise Price Of Share Options Exercised In Share-based Payment Arrangement2019 12 month |
|---|---|---|---|
| 2023-12-31 | $11.86 20-F · filed 2025-04-09 | ||
| 2023-09-30 | $2.93 6-K · filed 2024-11-12 | ||
| 2023-06-30 | $2.92 6-K · filed 2024-08-13 | ||
| 2022-12-31 | $6.36 20-F · filed 2025-04-09 |
CAD/shares
| Period end | Weighted Average Exercise Price Of Share Options Exercised In Share-based Payment Arrangement2019 12 month |
|---|---|
| 2023-12-31 | 11.86 CAD/shares 20-F · filed 2026-03-25 |